Department of Oto-rhino-laryngo Surgery, Centre Hospitalier Intercommunal de Créteil , Créteil , France.
Referral Center for Cardiac Amyloidosis, Filière Cardiogen and GRC Amyloid Research Institute , Créteil , France.
Amyloid. 2019 Dec;26(4):216-224. doi: 10.1080/13506129.2019.1646639. Epub 2019 Jul 31.
Systemic amyloidosis with cardiac involvement (CA) is a severe disease caused by the aggregation of misfolded proteins infiltrating organs and tissues and leading to their dysfunction. No study has yet focused on potential pharyngo-laryngeal impairments associated to CA. Our objective was to define its prevalence and describe pharyngo-laryngeal involvement patterns in a population with CA (light chain: AL, wild-type transthyretin: ATTRwt, variant transthyretin: ATTRv). Consecutive patients with a confirmed diagnosis of CA were prospectively investigated for pharyngo-laryngeal involvement. This included questionnaires on symptoms of dysphonia/dysphagia and quality of life Voice Handicap Index (VHI). In cases of dysphonia, a nasofibroscopy was performed to evaluate potential laryngeal organic lesions of amyloid infiltration and induced laryngeal dysfunction (mobility, glottic air leak). In cases of dysphagia, Video Endoscopy Swallowing Study (VESS) was performed to evaluate the presence of hypopharyngeal pooling at rest and during swallowing and the time of swallowing 80 ml of water. Ninety-five CA patients were enrolled, of whom 19 were ATTRv, 36 AL and 40 ATTRwt. Their mean age was 73.8 ± 9.2 years and the sex ratio was 2.6 in favor of men. Dysphagia was reported in 17% of the patients and 40% had more specific oropharyngeal symptoms (food sticking, regurgitation, change in dietary habits), preceding the CA diagnosis by 7 (0-24) months. Recent weight loss was reported in 60% of the patients (mean loss of 10 ± 6.3 kg). VESS showed functional swallowing impairment in only 4 patients without any macroscopic organic lesion. Dysphonia was reported in 36% of the patients (44% and 47% in AL and ATTRv sub-groups, respectively) of whom 40% had functional or organic laryngeal abnormality (14% of vocal fold mobility dysfunction and 26% of abnormal mucosa) without any macroscopic-specific lesions of amyloid infiltration in these patients. This prospective study suggests, for the first time, that amyloid associated with CA could infiltrate the various anatomical structures of the pharyngo-larynx, responsible for functional impairment and potential nutritional depletion and poor quality of life.
伴有心脏受累的系统性淀粉样变性(CA)是一种严重的疾病,由错误折叠的蛋白质聚集渗透到器官和组织并导致其功能障碍引起。目前尚无研究关注与 CA 相关的潜在咽喉损伤。我们的目的是确定其患病率,并描述 CA 患者(轻链:AL、野生型转甲状腺素蛋白:ATTRwt、变异转甲状腺素蛋白:ATTRv)的咽喉受累模式。连续前瞻性调查确诊为 CA 的患者的咽喉受累情况。这包括关于声音障碍/吞咽困难症状和生活质量嗓音障碍指数(VHI)的问卷调查。对于声音障碍患者,进行鼻纤维喉镜检查以评估潜在的咽喉淀粉样浸润的有机病变和诱导的喉功能障碍(运动、声门漏气)。对于吞咽困难患者,进行视频内镜吞咽研究(VESS)以评估在休息和吞咽时咽下部的积液情况以及吞咽 80ml 水的时间。 共纳入 95 例 CA 患者,其中 19 例为 ATTRv,36 例为 AL,40 例为 ATTRwt。他们的平均年龄为 73.8±9.2 岁,性别比例为 2.6,男性居多。17%的患者报告有吞咽困难,40%的患者有更具体的口咽症状(食物堵塞、反流、饮食习惯改变),在 CA 诊断前 7(0-24)个月出现。60%的患者报告近期体重减轻(平均减轻 10±6.3kg)。只有 4 名患者的 VESS 显示功能性吞咽障碍,但没有任何肉眼可见的器质性病变。36%的患者(AL 和 ATTRv 亚组分别为 44%和 47%)报告有声音障碍,其中 40%的患者有功能性或器质性喉异常(14%的声带运动功能障碍和 26%的异常黏膜),但在这些患者中没有发现任何肉眼可见的淀粉样浸润的特定病变。 这项前瞻性研究首次表明,与 CA 相关的淀粉样物质可能会渗透到咽喉的各种解剖结构,导致功能障碍和潜在的营养消耗以及生活质量下降。